Cargando…
Improved Alzheimer’s Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study
BACKGROUND: Distinguishing between Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD) results in poor diagnostic accuracy. OBJECTIVE: To investigate the utility of electroencephalography (EEG)-based biomarkers in comparison and in addition to established cerebrospinal fluid (CSF)...
Autores principales: | Laton, Jorne, Van Schependom, Jeroen, Goossens, Joery, Wiels, Wietse, Sieben, Anne, De Deyn, Peter Paul, Goeman, Johan, Streffer, Johannes, van der Zee, Julie, Martin, Jean-Jacques, Van Broeckhoven, Christine, De Vos, Maarten, Bjerke, Maria, Nagels, Guy, Engelborghs, Sebastiaan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789474/ https://www.ncbi.nlm.nih.gov/pubmed/36336933 http://dx.doi.org/10.3233/JAD-220693 |
Ejemplares similares
-
Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration
por: Goossens, Joery, et al.
Publicado: (2018) -
The genetics and neuropathology of frontotemporal lobar degeneration
por: Sieben, Anne, et al.
Publicado: (2012) -
TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies
por: Goossens, Joery, et al.
Publicado: (2015) -
The effect of task modality and stimulus frequency in paced serial addition tests on functional brain activity
por: Gielen, Jeroen, et al.
Publicado: (2018) -
TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort
por: van der Zee, Julie, et al.
Publicado: (2011)